2nd Quarter - Report — AMERICAN SOCIETY FOR MICROBIOLOGY for AMERICAN SOCIETY FOR MICROBIOLOGY (2022)

Firm

AMERICAN SOCIETY FOR MICROBIOLOGY

Client

AMERICAN SOCIETY FOR MICROBIOLOGY

Income

—

Expenses

$50,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

genomic sequencing and surveillance Tracking Pathogens Act (H.R.7152, S. 3534) Antimicrobial resistance (PASTEUR Act, S. 2076, STAAR Act, S. 3291) COVID-19 testing PREVENT Pandemics Act (S. 3799)

Lobbyist	Covered position, as disclosed
ALLEN SEGAL	—
MARY LEE WATTS	—

Contacted: SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 2076 (117th), S. 3534 (117th), S. 3291 (117th), S. 3799 (117th), H.R. 7152 (117th)

Budget/Appropriations BUD

Requests for FY 23 funding for NIH, CDC, BARDA, ASPR, USDA, NSF, Department of Energy Office of Science

Lobbyist	Covered position, as disclosed
AMALIA CORBY-EDWARDS New	—
ALLEN SEGAL	—
MARY LEE WATTS	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC)

Microbiome research coordination gain of function research of concern S. 1418, Bioeconomy and Research Development Act H.R.4521,Bioeconomy Research and Development Act S. 1260, U.S. Innovation and Competition Act H.R. 2225, NSF for the Future Act H.R.3593, S. 3699, Energy Sciences for the Future Act

Lobbyist	Covered position, as disclosed
AMALIA CORBY-EDWARDS New	—
MARY LEE WATTS	—

Contacted: Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1418 (117th), H.R. 2225 (117th), S. 3699 (117th), S. 1260 (117th), H.R. 4521 (117th), H.R. 3593 (117th)

Agriculture AGR

funding for research at USDA, NIFA

Lobbyist	Covered position, as disclosed
AMALIA CORBY-EDWARDS New	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

testing supply shortages diagnostic regulation H.R. 2148 VALID Act S. 2209, VALID Act H.R.6000 , Cures 2.0 pandemic preparedness and clinical lab role H.R.5602,BIO preparedness Workforce Act S. 3244, BIO Preparedness Workforce Act S. 610, Protecting Medicare and Farmers from Sequester Cuts Act

Lobbyist	Covered position, as disclosed
MARY LEE WATTS	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 6000 (117th), S. 3244 (117th), S. 2209 (117th), H.R. 5602 (117th), H.R. 2148 (117th), S. 610 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.